Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    January 2017
  1. JAUW YW, Zijlstra JM, de Jong D, Vugts DJ, et al
    Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
    PLoS One. 2017;12:e0169828.
    PubMed     Text format     Abstract available


  2. EL KARAK F, Bou-Orm IR, Ghosn M, Kattan J, et al
    PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma.
    PLoS One. 2017;12:e0170299.
    PubMed     Text format     Abstract available


  3. YANG F, Du J, Zhang H, Ruan G, et al
    Serum Metabolomics of Burkitt Lymphoma Mouse Models.
    PLoS One. 2017;12:e0170896.
    PubMed     Text format     Abstract available


  4. BEHESHTI A, Vanderburg C, McDonald JT, Ramkumar C, et al
    A Circulating microRNA Signature Predicts Age-Based Development of Lymphoma.
    PLoS One. 2017;12:e0170521.
    PubMed     Text format     Abstract available


  5. MPAKOU V, Papadavid E, Kontsioti F, Konsta E, et al
    Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate.
    PLoS One. 2017;12:e0170186.
    PubMed     Text format     Abstract available


  6. BRAUNE K, Volkmer I, Staege MS
    Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells.
    PLoS One. 2017;12:e0170694.
    PubMed     Text format     Abstract available


  7. YAHIAOUI A, Meadows SA, Sorensen RA, Cui ZH, et al
    PI3Kdelta inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kdelta and BTK inhibitors.
    PLoS One. 2017;12:e0171221.
    PubMed     Text format     Abstract available


  8. LACOSTE S, Bhatia S, Chen Y, Bhatia R, et al
    Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes.
    PLoS One. 2017;12:e0171473.
    PubMed     Text format     Abstract available


  9. KLEINSTERN G, Abu Seir R, Perlman R, Khatib A, et al
    Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians.
    PLoS One. 2017;12:e0171709.
    PubMed     Text format     Abstract available


  10. BROWNE SH, Diaz-Perez JA, Preziosi M, King CC, et al
    mTOR activity in AIDS-related diffuse large B-cell lymphoma.
    PLoS One. 2017;12:e0170771.
    PubMed     Text format     Abstract available


  11. BOGUSZ AM, Kovach AE, Le LP, Feng D, et al
    Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.
    PLoS One. 2017;12:e0172364.
    PubMed     Text format     Abstract available


  12. XU W, Wang Q, Shao A, Xu B, et al
    The performance of MR perfusion-weighted imaging for the differentiation of high-grade glioma from primary central nervous system lymphoma: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0173430.
    PubMed     Text format     Abstract available


  13. FLETCHER LB, Veenstra RN, Loo EY, Hwang AE, et al
    HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
    PLoS One. 2017;12:e0174457.
    PubMed     Text format     Abstract available


  14. ZHANG Y, Zhang R, Ding X, Peng B, et al
    FNC efficiently inhibits mantle cell lymphoma growth.
    PLoS One. 2017;12:e0174112.
    PubMed     Text format     Abstract available


  15. ZHOU X, Ma T, Zhang Y, Zhou N, et al
    Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0174648.
    PubMed     Text format     Abstract available


  16. YE X, Torabi M, Lix LM, Mahmud SM, et al
    Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.
    PLoS One. 2017;12:e0175701.
    PubMed     Text format     Abstract available


  17. WANG J, Zhou X, Liu Y, Li Z, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0176008.
    PubMed     Text format     Abstract available


  18. PROVENCIO M, Sabin P, Gomez-Codina J, Torrente M, et al
    Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.
    PLoS One. 2017;12:e0177204.
    PubMed     Text format     Abstract available


  19. YAMAZAKI H, Lai YC, Tateno M, Setoguchi A, et al
    Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition.
    PLoS One. 2017;12:e0177305.
    PubMed     Text format     Abstract available


  20. BOYE P, Serres F, Marescaux L, Hordeaux J, et al
    Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.
    PLoS One. 2017;12:e0177486.
    PubMed     Text format     Abstract available


  21. RENGSTL B, Kim S, Doring C, Weiser C, et al
    Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
    PLoS One. 2017;12:e0177378.
    PubMed     Text format     Abstract available


  22. MONDEJAR R, Perez C, Onaindia A, Martinez N, et al
    Molecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell lines.
    PLoS One. 2017;12:e0177524.
    PubMed     Text format     Abstract available


    January 2016
  23. LU T, Yu S, Liu Y, Yin C, et al
    Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma.
    PLoS One. 2016;11:e0148044.
    PubMed     Text format     Abstract available


  24. WANG XJ, Tang T, Farid M, Quek R, et al
    Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy.
    PLoS One. 2016;11:e0148901.
    PubMed     Text format     Abstract available


  25. GOSSMANN J, Stolte M, Lohoff M, Yu P, et al
    A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma.
    PLoS One. 2016;11:e0150411.
    PubMed     Text format     Abstract available


  26. KLUGE R, Chavdarova L, Hoffmann M, Kobe C, et al
    Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
    PLoS One. 2016;11:e0149072.
    PubMed     Text format     Abstract available


  27. GOPAL S, Fedoriw Y, Kaimila B, Montgomery ND, et al
    CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.
    PLoS One. 2016;11:e0150445.
    PubMed     Text format     Abstract available


  28. TERRAGNI R, Morselli-Labate AM, Vignoli M, Bottero E, et al
    Is Serum Total LDH Evaluation Able to Differentiate between Alimentary Lymphoma and Inflammatory Bowel Disease in a Real World Clinical Setting?
    PLoS One. 2016;11:e0151641.
    PubMed     Text format     Abstract available


  29. BI XW, Wang L, Zhang WW, Sun P, et al
    High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.
    PLoS One. 2016;11:e0152842.
    PubMed     Text format     Abstract available


  30. MATSUOKA S, Ishii Y, Nakao A, Abe M, et al
    Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation.
    PLoS One. 2016;11:e0150496.
    PubMed     Text format     Abstract available


  31. MASTORCI K, Muraro E, Pasini E, Furlan C, et al
    Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.
    PLoS One. 2016;11:e0153823.
    PubMed     Text format     Abstract available


  32. THOMSEN H, Inacio da Silva Filho M, Fuchs M, Ponader S, et al
    Evidence of Inbreeding in Hodgkin Lymphoma.
    PLoS One. 2016;11:e0154259.
    PubMed     Text format     Abstract available


  33. NEDELKOVSKA H, Rosenberg AF, Hilchey SP, Hyrien O, et al
    Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node.
    PLoS One. 2016;11:e0155347.
    PubMed     Text format     Abstract available


  34. ARBOE B, El-Galaly TC, Clausen MR, Munksgaard PS, et al
    The Danish National Lymphoma Registry: Coverage and Data Quality.
    PLoS One. 2016;11:e0157999.
    PubMed     Text format     Abstract available


  35. GRUENEISEN J, Sawicki LM, Schaarschmidt BM, Suntharalingam S, et al
    Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI.
    PLoS One. 2016;11:e0157880.
    PubMed     Text format     Abstract available


  36. JONA A, Miltenyi Z, Poliska S, Balint BL, et al
    Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.
    PLoS One. 2016;11:e0157651.
    PubMed     Text format     Abstract available


  37. CHEN YL, Lee CT, Lu CC, Yang SC, et al
    Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.
    PLoS One. 2016;11:e0158125.
    PubMed     Text format     Abstract available


  38. WU R, Nijland M, Rutgers B, Veenstra R, et al
    Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas.
    PLoS One. 2016;11:e0146624.
    PubMed     Text format     Abstract available


  39. HARRINGTON BK, Gardner HL, Izumi R, Hamdy A, et al
    Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.
    PLoS One. 2016;11:e0159607.
    PubMed     Text format     Abstract available


  40. MOYAL L, Feldbaum N, Goldfeiz N, Rephaeli A, et al
    The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
    PLoS One. 2016;11:e0146115.
    PubMed     Text format     Abstract available


  41. MAURYA AK, Vinayak M
    PI-103 and Quercetin Attenuate PI3K-AKT Signaling Pathway in T- Cell Lymphoma Exposed to Hydrogen Peroxide.
    PLoS One. 2016;11:e0160686.
    PubMed     Text format     Abstract available


  42. NYBAKKEN GE, Bala R, Gratzinger D, Jones CD, et al
    Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications.
    PLoS One. 2016;11:e0151735.
    PubMed     Text format     Abstract available


  43. TALHOUK A, Kommoss S, Mackenzie R, Cheung M, et al
    Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction.
    PLoS One. 2016;11:e0153844.
    PubMed     Text format     Abstract available


  44. SCHOB S, Meyer J, Gawlitza M, Frydrychowicz C, et al
    Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.
    PLoS One. 2016;11:e0161386.
    PubMed     Text format     Abstract available


  45. YU BH, Shui RH, Sheng WQ, Wang CF, et al
    Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases.
    PLoS One. 2016;11:e0161831.
    PubMed     Text format     Abstract available


  46. RANJBAR B, Krogh LB, Laursen MB, Primo MN, et al
    Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.
    PLoS One. 2016;11:e0153069.
    PubMed     Text format     Abstract available


  47. KO CC, Tai MH, Li CF, Chen TY, et al
    Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
    PLoS One. 2016;11:e0162565.
    PubMed     Text format     Abstract available


  48. KUZNETSOVA IS, Labutina EV, Hunter N
    Radiation Risks of Leukemia, Lymphoma and Multiple Myeloma Incidence in the Mayak Cohort: 1948-2004.
    PLoS One. 2016;11:e0162710.
    PubMed     Text format     Abstract available


  49. HOSHINA S, Sekizuka T, Kataoka M, Hasegawa H, et al
    Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines.
    PLoS One. 2016;11:e0162574.
    PubMed     Text format     Abstract available


  50. CRANE GM, Samols MA, Morsberger LA, Yonescu R, et al
    Tumor-Infiltrating Macrophages in Post-Transplant, Relapsed Classical Hodgkin Lymphoma Are Donor-Derived.
    PLoS One. 2016;11:e0163559.
    PubMed     Text format     Abstract available


  51. BUETTI-DINH A, O'Hare T, Friedman R
    Sensitivity Analysis of the NPM-ALK Signalling Network Reveals Important Pathways for Anaplastic Large Cell Lymphoma Combination Therapy.
    PLoS One. 2016;11:e0163011.
    PubMed     Text format     Abstract available


  52. CAI Q, Chen K, Chen J, Wu S, et al
    The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
    PLoS One. 2016;11:e0164210.
    PubMed     Text format     Abstract available


  53. YANG YT, Tai CJ, Chen C, Wu HC, et al
    Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review.
    PLoS One. 2016;11:e0161811.
    PubMed     Text format     Abstract available


  54. ASENBAUM U, Nolz R, Karanikas G, Furtner J, et al
    Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
    PLoS One. 2016;11:e0164118.
    PubMed     Text format     Abstract available


  55. ALRIC L, Besson C, Lapidus N, Jeannel J, et al
    Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
    PLoS One. 2016;11:e0162965.
    PubMed     Text format     Abstract available


  56. QUENTMEIER H, Drexler HG, Hauer V, MacLeod RA, et al
    Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.
    PLoS One. 2016;11:e0167599.
    PubMed     Text format     Abstract available


  57. PARSONS E, Otieno JA, Ong'echa JM, Nixon CE, et al
    Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study.
    PLoS One. 2016;11:e0167841.
    PubMed     Text format     Abstract available


  58. COMBER H, De Camargo Cancela M, Haase T, Johnson H, et al
    Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.
    PLoS One. 2016;11:e0168684.
    PubMed     Text format     Abstract available


    January 2015
  59. DAI H, Ehrentraut S, Nagel S, Eberth S, et al
    Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
    PLoS One. 2015;10:e0139663.
    PubMed     Text format     Abstract available


  60. FONTINHA D, Lopes FB, Marques S, Alenquer M, et al
    Correction: Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells.
    PLoS One. 2015;10:e0145942.
    PubMed     Text format     Abstract available


  61. YING J, Lin C, Wu J, Guo L, et al
    Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
    PLoS One. 2015;10:e0144731.
    PubMed     Text format     Abstract available


  62. KNUDSEN S, Hother C, Gronbaek K, Jensen T, et al
    Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL.
    PLoS One. 2015;10:e0115538.
    PubMed     Text format     Abstract available


  63. CEN H, Tan X, Guo B
    A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
    PLoS One. 2015;10:e0145037.
    PubMed     Text format     Abstract available


  64. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  65. STEINHILBER J, Bonin M, Walter M, Fend F, et al
    Next-generation sequencing identifies deregulation of microRNAs involved in both innate and adaptive immune response in ALK+ ALCL.
    PLoS One. 2015;10:e0117780.
    PubMed     Text format     Abstract available


  66. XAVIER DE CARVALHO A, Maiato H, Maia AF, Ribeiro SA, et al
    Reed-Sternberg cells form by abscission failure in the presence of functional Aurora B kinase.
    PLoS One. 2015;10:e0124629.
    PubMed     Text format     Abstract available


  67. JOBSRI J, Allen A, Rajagopal D, Shipton M, et al
    Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.
    PLoS One. 2015;10:e0118096.
    PubMed     Text format     Abstract available


  68. SIMBIRI KO, Smith NA, Otieno R, Wohlford EE, et al
    Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.
    PLoS One. 2015;10:e0125420.
    PubMed     Text format     Abstract available


  69. PACIELLO G, Acquaviva A, Pighi C, Ferrarini A, et al
    VDJSeq-Solver: in silico V(D)J recombination detection tool.
    PLoS One. 2015;10:e0118192.
    PubMed     Text format     Abstract available


  70. GRITTI G, Boschini C, Rossi A, Delaini F, et al
    Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.
    PLoS One. 2015;10:e0121822.
    PubMed     Text format     Abstract available


  71. YU X, Luo Y, Liu J, Liu Y, et al
    TOX acts an oncological role in mycosis fungoides.
    PLoS One. 2015;10:e0117479.
    PubMed     Text format     Abstract available


  72. VIOLLET C, Davis DA, Reczko M, Ziegelbauer JM, et al
    Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
    PLoS One. 2015;10:e0126439.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: